Sevoflurane Promotes Neurodegeneration Through Inflammasome Formation in APP/PS1 Mice
Sevoflurane (SEVO) is a highly fluorinated methyl isopropyl ether used as an inhalational anesthetic for general anesthesia. Previous studies have shown that SEVO may induce impaired memory and recognition ability and may be associated with neurodegenerative disease, e.g., Alzheimer’s disease (AD)....
Guardado en:
Autores principales: | Guohua Li, Yu Wang, Fang Cao, Dawei Wang, Limin Zhou, Yanwu Jin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/013c29a205304399a952675c90aa89bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Electroencephalogram Signatures of Agitation Induced by Sevoflurane and Its Association With Genetic Polymorphisms
por: Shuai Zhao, et al.
Publicado: (2021) -
MAC-Sparing Effect of Transdermal Fentanyl in Sevoflurane-Anesthetized Sheep
por: Lauren Duffee, et al.
Publicado: (2018) -
Mechanism underlying sevoflurane-induced protection in cerebral ischemia–reperfusion injury
por: Chen Bing, et al.
Publicado: (2021) -
Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson’s Disease: An Up-and-Down Sequential Allocation Trial
por: Yang C, et al.
Publicado: (2021) -
A comparative study of propofol based total intravenous anesthesia and sevoflurane based volatile induction and maintenance anesthesia on post-operative recovery profile in elective tonsillectomy
por: Sarfaraz Ahmed, et al.
Publicado: (2021)